drug · small molecule
patient view →TOFACITINIB CITRATE
Phase 1updated 2mo agoby $SIGY Sigyn Therapeutics, Inc.🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for rheumatoid arthritis and psoriatic arthritis and 4 investigational indications.
targets
Janus Kinase (JAK)
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that